MAPT and Alzheimer disease: The NIA-AA framework thereforesuggests the A/T/N biomarker classification scheme in AD and brain aging research,where “A” refers to biomarkers of Aß, “T” stands for biomarkers of tau pathology,and “N” refers to biomarkers of neurodegeneration or neuronal injury [2].